Renal composite outcomes in previous GLP-1 RA trials have typically included progression of albuminuria, sustained decline in estimated glomerular filtration rate (eGFR), and, in some cases, kidney failure [14,15]. This evidence concerns the gene GLP1R and kidney failure.